FDG-PET scanning in the diagnosis of gastrointestinal cancers

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

2002 • 4,254 citations

Cancer statistics, 1999

1999 • 3,154 citations

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

2003 • 2,216 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

1992 • 1,170 citations

Hereditary Pancreatitis and the Risk of Pancreatic Cancer

1997 • 968 citations

Gastrointestinal stromal tumors: Recent advances in understanding of their biology

1999 • 850 citations

Elevated Levels of Glucose Transport and Transporter Messenger RNA Are Induced by ras or src Oncogenes

1987 • 789 citations

Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging

2001 • 714 citations

Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

2000 • 577 citations

Management of malignant gastrointestinal stromal tumours

2002 • 574 citations

An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

1993 • 432 citations

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

1998 • 430 citations

A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

2000 • 430 citations

Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography

2001 • 401 citations

Clinical perspective of human colorectal cancer metastasis

1984 • 384 citations

A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584.

1991 • 383 citations

Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation

1996 • 381 citations

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.

1997 • 313 citations

Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer

1999 • 297 citations

Staging recurrent metastatic colorectal carcinoma with PET.

1997 • 296 citations

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma

2002 • 287 citations

Clinical role of positron emission tomography in oncology

2001 • 286 citations

Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography

1997 • 272 citations

Value of Positron Emission Tomography With [F-18]Fluorodeoxyglucose in Patients With Colorectal Liver Metastases: A Prospective Study

2002 • 271 citations

Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography

1997 • 263 citations

Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

1996 • 257 citations

Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal Cancer

1998 • 255 citations

The Role of Whole-Body Positron Emission Tomography With [18F]Fluorodeoxyglucose in Identifying Operable Colorectal Cancer Metastases to the Liver

1996 • 253 citations

Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-<scp>d</scp>-glucose in Recurrent Colorectal Cancer

1999 • 243 citations

Discussion

1999 • 239 citations

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

1995 • 236 citations

Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver

1996 • 234 citations

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

2002 • 231 citations

Delayed18F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas

2000 • 226 citations

Clinical Impact of ¹⁸F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study

2001 • 226 citations

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.

1999 • 222 citations

18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography

1991 • 216 citations

Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases

1997 • 204 citations

FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.

1998 • 202 citations

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

1997 • 197 citations

Positron emission tomography for staging of oesophageal and gastroesophageal malignancy

1998 • 190 citations

18Fluorodeoxyglucose-Positron Emission Tomography in the Management of Patients With Suspected Pancreatic Cancer

1999 • 189 citations

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

1994 • 184 citations

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.

1995 • 181 citations

Values and Limitations of 18F-Fluorodeoxyglucose???Positron-Emission Tomography with Preoperative Evaluation of Patients with Pancreatic Masses

2000 • 169 citations

Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.

1995 • 161 citations

Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

1997 • 151 citations

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.

1995 • 151 citations

Detection of liver metastases from pancreatic cancer using FDG PET.

1999 • 147 citations

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma

1998 • 147 citations

FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

1998 • 144 citations

Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography

2001 • 138 citations

Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-<scp>d</scp>-glucose for the differentiation of chronic pancreatitis and pancreatic cancer

1999 • 137 citations

Value of 18-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients With Cystic Tumors of the Pancreas

2001 • 125 citations

Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer

2002 • 125 citations

Physicochemical Properties and Isoenzyme Composition of Hexokinase From Normal and Malignant Human Tissues

1978 • 123 citations

Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)

2002 • 120 citations

FDG–PET in the prediction of survival of patients with cancer of the pancreas: a pilot study

2000 • 117 citations

Liver metastases

1981 • 108 citations

Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis

1987 • 100 citations

Diagnostic usefulness of FDG PET for pancreatic mass lesions

2001 • 93 citations

Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PET

2000 • 86 citations

Decision Analysis for the Cost-Effective Management of Recurrent Colorectal Cancer

2001 • 85 citations

Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer

2001 • 74 citations

Positron Emission Tomography Affects Surgical Management in Recurrent Colorectal Cancer Patients

2003 • 74 citations

Fluorodeoxyglucose Positron Emission Tomography and the Prognosis of Pancreatic Carcinoma

2000 • 72 citations

Gastrointestinal Stromal Tumors

2010 • 70 citations

Hexokinase, differentiation and growth rates of transplanted rat tumors.

1970 • 69 citations

PET-FDG as predictor of therapy response in patients with colorectal carcinoma.

2003 • 69 citations

Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

1997 • 65 citations

Local recurrence of rectal cancer:evaluation with F-18 fluorodeoxyglucose PET imaging

1997 • 64 citations

Gastrointestinal stromal tumors

2001 • 63 citations

Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.

1996 • 63 citations

FDG-PET improves the management of patients with suspected recurrence of colorectal cancer

2002 • 52 citations

FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer

2002 • 51 citations

Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer

2001 • 46 citations

Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?

2001 • 43 citations

The Possible Role of F-18 FDG Positron Emission Tomography in the Differential Diagnosis of Focal Pancreatic Lesions

2002 • 39 citations

F-18 FDG PET Imaging in Gastrointestinal Stromal Tumor

2003 • 32 citations

The role of anti-p53-autoantibodies in pancreatic disorders

1996 • 30 citations

Epidemiology and pathogenesis of esophageal cancer: Management and its controversial results (Review)

2003 • 20 citations

Analysis of K-ras Codon 12 Point Mutations Using Duodenal Lavage Fluid for Diagnosis of Pancreatic Carcinoma

1999 • 14 citations

An FDG Positron Emission Tomographic Study in a Case of Gastrointestinal Stromal Tumor

2003 • 3 citations